Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study.
diagnostic delay
disease outcome
tertiary care
Journal
Therapeutic advances in gastroenterology
ISSN: 1756-283X
Titre abrégé: Therap Adv Gastroenterol
Pays: England
ID NLM: 101478893
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
09
2019
accepted:
20
11
2019
entrez:
13
2
2020
pubmed:
13
2
2020
medline:
13
2
2020
Statut:
epublish
Résumé
Inflammatory bowel disease (IBD) needs early interventions and an individual specialist-patient relationship. Distance from a tertiary IBD center might affect patient's disease course and outcome. We investigated whether the patient-to-specialist distance has an impact on the disease course using the well-defined patient collective of the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Patient's home address at diagnosis (postal zip code) was extracted from the SIBDCS database. Distance between each zip code and the nearest located IBD specialist center was calculated and classified into the following three sections based on proximity: <10 km (group 1); 10-35 km (group 2); >35 km (group 3). Our study included in total 408 IBD patients [234 Crohn's disease (CD), 154 ulcerative colitis (UC), 20 IBD unclassified (IBDU)]. Median age was lowest in group 2 at diagnosis (G1: 28 years; G2: 21 years, G3: 26 years, Patient-to-specialist distance might affect drug treatment. However, disease course and the need for IBD-related surgery does not seem to be associated with a longer distance to specialist care in Switzerland.
Sections du résumé
BACKGROUND
BACKGROUND
Inflammatory bowel disease (IBD) needs early interventions and an individual specialist-patient relationship. Distance from a tertiary IBD center might affect patient's disease course and outcome. We investigated whether the patient-to-specialist distance has an impact on the disease course using the well-defined patient collective of the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).
METHODS
METHODS
Patient's home address at diagnosis (postal zip code) was extracted from the SIBDCS database. Distance between each zip code and the nearest located IBD specialist center was calculated and classified into the following three sections based on proximity: <10 km (group 1); 10-35 km (group 2); >35 km (group 3).
RESULTS
RESULTS
Our study included in total 408 IBD patients [234 Crohn's disease (CD), 154 ulcerative colitis (UC), 20 IBD unclassified (IBDU)]. Median age was lowest in group 2 at diagnosis (G1: 28 years; G2: 21 years, G3: 26 years,
CONCLUSIONS
CONCLUSIONS
Patient-to-specialist distance might affect drug treatment. However, disease course and the need for IBD-related surgery does not seem to be associated with a longer distance to specialist care in Switzerland.
Identifiants
pubmed: 32047533
doi: 10.1177/1756284819895217
pii: 10.1177_1756284819895217
pmc: PMC6984432
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1756284819895217Informations de copyright
© The Author(s), 2020.
Déclaration de conflit d'intérêts
Conflict of interest: The authors declare that there is no conflict of interest.
Références
Am J Gastroenterol. 2013 Nov;108(11):1744-53; quiz 1754
pubmed: 23978953
Dig Dis Sci. 2016 Nov;61(11):3278-3284
pubmed: 27207180
Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S209-16
pubmed: 20117344
Inflamm Bowel Dis. 2017 Jul;23(7):1234-1239
pubmed: 28520589
Curr Opin Gastroenterol. 2013 Jul;29(4):357-62
pubmed: 23695429
World J Gastroenterol. 2008 Sep 28;14(36):5512-8
pubmed: 18810768
Gastroenterology. 2008 Mar;134(3):680-7
pubmed: 18242604
Oncologist. 2015 Dec;20(12):1378-85
pubmed: 26512045
Aliment Pharmacol Ther. 2015 Oct;42(8):977-89
pubmed: 26271358
Inflamm Bowel Dis. 2011 Jan;17(1):423-39
pubmed: 20564651
N Engl J Med. 2004 Feb 26;350(9):876-85
pubmed: 14985485
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
Z Gastroenterol. 2018 Sep;56(9):1087-1169
pubmed: 30206914
Inflamm Bowel Dis. 2016 Sep;22(9):2149-57
pubmed: 27482978
Inflamm Bowel Dis. 2002 Nov;8(6):382-9
pubmed: 12454613
Am J Gastroenterol. 2008 Nov;103(11):2789-98
pubmed: 18684184
Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
Gastroenterology. 2015 Jan;148(1):52-63.e3
pubmed: 25241327
Clin Gastroenterol Hepatol. 2007 May;5(5):597-601
pubmed: 17382602
World J Gastroenterol. 2017 Sep 21;23(35):6474-6481
pubmed: 29085197
Ther Adv Chronic Dis. 2018 Feb;9(2):65-72
pubmed: 29387331
Ann Thorac Surg. 2015 Dec;100(6):2213-8
pubmed: 26271578
Praxis (Bern 1994). 2011 Nov 16;100(23):1413-24
pubmed: 22086380
BMJ Open. 2016 Nov 24;6(11):e013059
pubmed: 27884848
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1430-8
pubmed: 18054751
Gut. 2012 Oct;61(10):1410-6
pubmed: 22684482
J Crohns Colitis. 2016 Jan;10(1):55-60
pubmed: 26520164
Curr Treat Options Gastroenterol. 2018 Mar;16(1):129-146
pubmed: 29411220
Int J Epidemiol. 2009 Aug;38(4):922-31
pubmed: 18782896
Inflamm Bowel Dis. 2012 Mar;18(3):496-505
pubmed: 21509908
N Engl J Med. 2005 Dec 8;353(23):2462-76
pubmed: 16339095